Literature DB >> 19877628

Total synthesis of vinigrol.

Thomas J Maimone1, Jun Shi, Shinji Ashida, Phil S Baran.   

Abstract

The longstanding challenge posed by the complex diterpene vinigrol has been answered for the first time. The notorious difficulty in synthesizing vinigrol stems from its unprecedented decahydro-1,5-butanonaphthalene ring system, eight contiguous stereocenters, and highly congested functionality. This Communication delineates a stereocontrolled 23-step route to vinigrol that is scalable (>5 g prepared of a late-stage intermediate), minimally reliant on protecting group chemistry, and facilitated by a number of unique and chemoselective transformations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877628      PMCID: PMC2787793          DOI: 10.1021/ja908194b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  14 in total

1.  Synthesis of the complete carbocyclic skeleton of vinigrol.

Authors:  Lionel Gentric; Issam Hanna; Louis Ricard
Journal:  Org Lett       Date:  2003-04-03       Impact factor: 6.005

2.  Synthesis of the tricyclic core of vinigrol via an intramolecular Diels-Alder reaction.

Authors:  Christiane M Grisé; Guillaume Tessier; Louis Barriault
Journal:  Org Lett       Date:  2007-03-16       Impact factor: 6.005

3.  Vinigrol, a novel antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria nigra. I. Taxonomy, fermentation, isolation, physicochemical and biological properties.

Authors:  T Ando; Y Tsurumi; N Ohata; I Uchida; K Yoshida; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1988-01       Impact factor: 2.649

4.  Mass spectrometry of nucleic acid components. Trimethylsilyl derivatives of nucleotides, nucleosides, and bases.

Authors:  J A McCloskey; A M Lawson; K Tsuboyama; P M Krueger; R N Stillwell
Journal:  J Am Chem Soc       Date:  1968-07-17       Impact factor: 15.419

5.  Exploratory studies aimed at a synthesis of vinigrol. 2. Attempts to exploit ring-closing metathesis for construction of the central cyclooctane belt.

Authors:  Leo A Paquette; Ivan Efremov; Zuosheng Liu
Journal:  J Org Chem       Date:  2005-01-21       Impact factor: 4.354

6.  Exploratory studies aimed at a synthesis of vinigrol. 4. Probe of possible means for direct connection of the side arms and of ring-contraction alternatives.

Authors:  Leo A Paquette; Zuosheng Liu; Ivan Efremov
Journal:  J Org Chem       Date:  2005-01-21       Impact factor: 4.354

7.  Studies toward the total synthesis of vinigrol. synthesis of the octalin ring.

Authors:  Louis Morency; Louis Barriault
Journal:  J Org Chem       Date:  2005-10-28       Impact factor: 4.354

8.  Convergent enantioselective synthesis of vinigrol, an architecturally novel diterpenoid with potent platelet aggregation inhibitory and antihypertensive properties. 1. Application of anionic sigmatropy to construction of the octalin substructure.

Authors:  Leo A Paquette; Ronan Guevel; Shuichi Sakamoto; In Ho Kim; Jason Crawford
Journal:  J Org Chem       Date:  2003-08-08       Impact factor: 4.354

9.  Vinigrol, a novel antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria nigra. II. Pharmacological characteristics.

Authors:  T Ando; K Yoshida; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1988-01       Impact factor: 2.649

10.  Rapid assembly of vinigrol's unique carbocyclic skeleton.

Authors:  Jason G M Morton; Cristian Draghici; Laura D Kwon; Jon T Njardarson
Journal:  Org Lett       Date:  2009-10-15       Impact factor: 6.005

View more
  12 in total

Review 1.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

2.  Synthetic Approaches and Total Syntheses of Vinigrol, a Unique Diterpenoid.

Authors:  Cristian Draghici; Jon T Njardarson
Journal:  Tetrahedron       Date:  2015-06-10       Impact factor: 2.457

3.  Evolution of an oxidative dearomatization enabled total synthesis of vinigrol.

Authors:  Qingliang Yang; Cristian Draghici; Jon T Njardarson; Fang Li; Brandon R Smith; Pradipta Das
Journal:  Org Biomol Chem       Date:  2014-01-14       Impact factor: 3.876

4.  Why a proximity-induced Diels-Alder reaction is so fast.

Authors:  Elizabeth H Krenske; Emma W Perry; Steven V Jerome; Thomas J Maimone; Phil S Baran; K N Houk
Journal:  Org Lett       Date:  2012-05-25       Impact factor: 6.005

5.  An approach to mimicking the sesquiterpene cyclase phase by nickel-promoted diene/alkyne cooligomerization.

Authors:  Dane Holte; Daniel C G Götz; Phil S Baran
Journal:  J Org Chem       Date:  2012-01-03       Impact factor: 4.354

6.  Total syntheses of the squalene-derived halogenated polyethers ent-dioxepandehydrothyrsiferol and armatol A via bromonium- and Lewis acid-initiated epoxide-opening cascades.

Authors:  Brian S Underwood; Jessica Tanuwidjaja; Sze-Sze Ng; Timothy F Jamison
Journal:  Tetrahedron       Date:  2013-06-24       Impact factor: 2.457

7.  Total synthesis of vinigrol.

Authors:  Qingliang Yang; Jon T Njardarson; Cristian Draghici; Fang Li
Journal:  Angew Chem Int Ed Engl       Date:  2013-07-01       Impact factor: 15.336

8.  Synthesis of highly functionalized β-aminocyclopentanecarboxylate stereoisomers by reductive ring opening reaction of isoxazolines.

Authors:  Melinda Nonn; Loránd Kiss; Reijo Sillanpää; Ferenc Fülöp
Journal:  Beilstein J Org Chem       Date:  2012-01-17       Impact factor: 2.883

9.  Academia-industry symbiosis in organic chemistry.

Authors:  Quentin Michaudel; Yoshihiro Ishihara; Phil S Baran
Journal:  Acc Chem Res       Date:  2015-02-23       Impact factor: 22.384

10.  A one-pot synthesis of 3-trifluoromethyl-2-isoxazolines from trifluoromethyl aldoxime.

Authors:  Raoni S B Gonçalves; Michael Dos Santos; Guillaume Bernadat; Danièle Bonnet-Delpon; Benoit Crousse
Journal:  Beilstein J Org Chem       Date:  2013-11-07       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.